We are live on ! Find out more
BLTE

Belite Bio
BLTE

69 hedge funds and large institutions have $1.15B invested in Belite Bio in 2025 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 4

581% more capital invested

Capital invested by funds: $169M → $1.15B (+$984M)

103% more funds holding

Funds holding: 34 → 69 (+35)

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

11.98% more ownership

Funds ownership: 7.19% → 19.17% (+12%)

Holders
69
Holders Change
+35
Holders Change %
+102.94%
% of All Funds
0.84%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
40
Increased
17
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DGM
Darwin Global Management
Jersey
+$359M
2
Millennium Management
Millennium Management
New York
+$63.7M
3
RI
RTW Investments
New York
+$47.7M
4
PA
Perceptive Advisors
New York
+$43.2M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$33.3M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$52.4M
2
VPC
Vestal Point Capital
New York
-$23.1M
3
SCM
Soleus Capital Management
Connecticut
-$20.1M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.16M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
AGP
26
Artia Global Partners
Florida
$2.88M +$2.13M +17,989 New
State Street
27
State Street
Massachusetts
$2.52M +$292K +2,467 +19%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$2.5M +$1.84M +15,538 New
EAM
29
Exome Asset Management
New York
$2.29M +$1.7M +14,328 New
Ameriprise
30
Ameriprise
Minnesota
$2.11M +$1.21M +10,190 +336%
BFM
31
Boothbay Fund Management
New York
$1.9M +$1.41M +11,897 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$1.67M -$614K -5,180 -33%
SC
33
Stempoint Capital
New York
$1.47M +$1.09M +9,163 New
SFCM
34
Seven Fleet Capital Management
California
$1.47M +$1.09M +9,161 New
HF
35
HRT Financial
New York
$1.3M +$967K +8,164 New
Wellington Management Group
36
Wellington Management Group
Massachusetts
$991K +$734K +6,198 New
Citadel Advisors
37
Citadel Advisors
Florida
$809K -$684K -5,772 -53%
SP
38
SmartHarvest Portfolios
Washington
$669K +$496K +4,184 New
Barclays
39
Barclays
United Kingdom
$668K +$495K +4,176 New
HNWAG
40
High Net Worth Advisory Group
Florida
$560K – – –
PR
41
PSP Research
Pennsylvania
$551K +$408K +3,443 New
YIH
42
Y-Intercept (HK)
Hong Kong
$504K +$373K +3,152 New
PCM
43
Prelude Capital Management
New York
$499K +$369K +3,119 New
AIP
44
Arrowpoint Investment Partners
Singapore
$488K +$361K +3,049 New
SG Americas Securities
45
SG Americas Securities
New York
$441K +$326K +2,755 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$392K -$1.08M -9,101 -79%
YCG
47
Yeomans Consulting Group
Georgia
$384K +$284K +2,399 New
Citigroup
48
Citigroup
New York
$342K -$222K -1,873 -47%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$334K +$248K +2,092 New
IFG
50
Independent Financial Group
California
$320K +$237K +2,000 New
1
2
3

BLTE Hedge Fund Activity: Q4 2025 in Review

69 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q4 2025, worth a combined $1.15B — up 581% from $169M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new BLTE positions and 4 closed out — a net gain of 36 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was Darwin Global Management, opening a new position worth an estimated $359M. The largest seller was RA Capital Management, cutting an estimated $52.4M.

  • 69 institutional investors held Belite Bio (BLTE) as of Q4 2025, up from 34 in Q3 2025.
  • Funds reported $1.15B of Belite Bio stock for Q4 2025, up 581% quarter-over-quarter.
  • 40 funds opened new Belite Bio positions in Q4 2025 and 4 closed out, a net change of +36 holders.
  • The largest Belite Bio buyer in Q4 2025 was Darwin Global Management, an estimated $359M added.
  • The largest Belite Bio seller in Q4 2025 was RA Capital Management, an estimated $52.4M sold.

Based on aggregated 13F filings for Q4 2025.